Recursion Pharmaceuticals (NasdaqGS:RXRX) Jumps 12% Following US$500M Equity Offering [Yahoo! Finance]
Recursion Pharmaceuticals, Inc. - Class A (RXRX)
Company Research
Source: Yahoo! Finance
The company announced a significant follow-on equity offering of $500 million, which may have attracted investor attention. Additionally, Recursion's reported earnings for FY 2024 showed growth in sales and revenue despite a widening net loss, providing mixed signals to the market. These strategic maneuvers coincided with broader market trends where major indices such as the Nasdaq have faced volatile trading conditions, partly due to uncertainty in the tech sector and general market fluctuations. Against this backdrop, Recursion's market activity appeared resilient, perhaps benefiting from its forward-looking positioning compared to broader concerns around tariffs and economic growth that pressured many tech and pharmaceutical s
Read more
Impact Snapshot
Event Time:
RXRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RXRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RXRX alerts
High impacting Recursion Pharmaceuticals, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
RXRX
News
- Is Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) the Best AI Stock to Invest in According to Reddit? [Yahoo! Finance]Yahoo! Finance
- Why Startup Studios Are The Ultimate Builders Of Deep-Tech Ventures [Forbes]Forbes
- Why Recursion Pharmaceuticals (RXRX) Dipped More Than Broader Market Today [Yahoo! Finance]Yahoo! Finance
- Why Recursion Pharmaceuticals (RXRX) Went Up on Monday? [Yahoo! Finance]Yahoo! Finance
- Recursion Bolsters Board of Directors with Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine SunGlobeNewswire
RXRX
Earnings
- 2/28/25 - Miss
RXRX
Sec Filings
- 3/28/25 - Form 4
- 3/27/25 - Form 144
- 3/19/25 - Form 4
- RXRX's page on the SEC website